Skip to content
healthcare.dev
Get a free key

Halaven

NDC 43624-002, eribulin mesylate, injection, from BSP Pharmaceuticals SpA.

Product NDC
43624-002
Status
Listed
Labeler
BSP Pharmaceuticals SpA
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA201532
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/43624-002 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ERIBULIN MESYLATE1 mg/2mL

Pharmacologic classes

Microtubule Inhibition [PE]; Microtubule Inhibitor [EPC]

Package NDCNDC-11Package
43624-002-0143624000201100 VIAL in 1 TRAY (43624-002-01) / 2 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/8fc8fe1d-59fe-4e43-a95c-e7aa13422cd6

Use it

Look up 43624-002 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/43624-002 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 43624-002. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.